The A's, G's, C's, and T's of health disparities

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Ramos, Edward ^a   Rotimi, Charles ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DNA; G PROTEIN COUPLED RECEPTOR KINASE 5;

AMERICAN INDIAN; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; ATTRIBUTABLE RISK; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC DISEASE; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG EFFICACY; ETHNIC GROUP; EUROPEAN AMERICAN; FRAGILE X SYNDROME; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HEART FAILURE; HEART INFARCTION; HISPANIC; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; HYPERTENSION; LIVER DISEASE; MEDICAL TECHNOLOGY; MIGRATION; MINORITY HEALTH; MORTALITY; PACIFIC ISLANDER; POPULATION GENETICS; POPULATION RISK; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK FACTOR; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STATUS; SOCIOECONOMICS; STROKE; SURVIVAL RATE; UNITED STATES;

EID: 67650766641     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-29     Document Type: Article

References (40)

1. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. Office of Management and Budget, Federal Register 1997 62FR58781 58790
2. Understanding and Using Human Genetic Variation Knowledge in the Design and Conduct of Biomedical Research. CN Rotimi, 2005 http://www.bcm.edu/edict/ PDF/Scientific-Rationale.pdf
3. Health, United States, 2007 With Chartbook on Trends in Health of Americans. National Center for Health Statistics, Hyattsville, MD 2007
4. A haplotype map of the human genome. The International HapMap Consortium, Nature 2005 437 1299 1320 16255080 10.1038/nature04226
5. Ice Ages and the mitochondrial DNA chronology of human dispersals: a review. P Forster, Philosophical transactions of the Royal Society of London 2004 359 255 264 discussion 264 15101581 10.1098/rstb.2003.1394
6. Mitochondrial genome variation and the origin of modern humans. M Ingman H Kaessmann S Paabo U Gyllensten, Nature 2000 408 708 713 10.1038/35047064 11130070
7. The role of selection in the evolution of human mitochondrial genomes. T Kivisild P Shen DP Wall B Do R Sung K Davis G Passarino PA Underhill C Scharfe A Torroni, Genetics 2006 172 373 387 16172508 10.1534/genetics.105.043901
8. Modern human origins: progress and prospects. C Stringer, Philosophical transactions of the Royal Society of London 2002 357 563 579 12028792 10.1098/rstb.2001.1057
9. Genetic and fossil evidence for the origin of modern humans. CB Stringer P Andrews, Science 1988 239 1263 1268 10.1126/science.3125610 3125610 (Pubitemid 18299222)
10. Late Pleistocene human skull from Hofmeyr, South Africa, and modern human origins. FE Grine RM Bailey K Harvati RP Nathan AG Morris GM Henderson I Ribot AW Pike, Science 2007 315 226 229 10.1126/science.1136294 17218524
11. Patterns of human genetic diversity: implications for human evolutionary history and disease. SA Tishkoff BC Verrelli, Annual review of genomics and human genetics 2003 4 293 340 10.1146/annurev.genom.4.070802.110226
12. The impact of next-generation sequencing technology on genetics. ER Mardis, Trends Genet 2008 24 133 141 18262675
13. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. TA Manolio LL Rodriguez L Brooks G Abecasis D Ballinger M Daly P Donnelly SV Faraone K Frazer S Gabriel, Nature genetics 2007 39 1045 1051 10.1038/ng2127 17728769
14. A HapMap harvest of insights into the genetics of common disease. TA Manolio LD Brooks FS Collins, The Journal of clinical investigation 2008 118 1590 1605 18451988 10.1172/JCI34772
15. Long-term trends in the incidence of and survival with heart failure. D Levy S Kenchaiah MG Larson EJ Benjamin MJ Kupka KK Ho JM Murabito RS Vasan, The New England journal of medicine 2002 347 1397 1402 10.1056/NEJMoa020265 12409541
16. Trends in heart failure incidence and survival in a community-based population. VL Roger SA Weston MM Redfield JP Hellermann-Homan J Killian BP Yawn SJ Jacobsen, Jama 2004 292 344 350 10.1001/jama.292.3.344 15265849
17. Relational pathways between socioeconomic position and cardiovascular risk in a multiethnic urban sample: complexities and their implications for improving health in economically disadvantaged populations. AJ Schulz JS House BA Israel G Mentz JT Dvonch PY Miranda S Kannan M Koch, Journal of epidemiology and community health 2008 62 638 646 10.1136/jech.2007.063222
18. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. P Carson S Ziesche G Johnson JN Cohn, Journal of cardiac failure 1999 5 178 187 10.1016/S1071-9164(99)90001-5 10496190
19. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. DV Exner DL Dries MJ Domanski JN Cohn, The New England journal of medicine 2001 344 1351 1357 10.1056/NEJM200105033441802 11333991
20. Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. DL Dries MH Strong RS Cooper MH Drazner, Journal of the American College of Cardiology 2002 40 311 317 10.1016/S0735-1097(02)01943-5 12106937
21. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. The Beta-Blocker Evaluation of Survival Trial Investigators, The New England journal of medicine 2001 344 1659 1667 10.1056/NEJM200105313442202 11386264
22. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. CW Yancy MB Fowler WS Colucci EM Gilbert MR Bristow JN Cohn MA Lukas ST Young M Packer, The New England journal of medicine 2001 344 1358 1365 10.1056/NEJM200105033441803 11333992
23. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. SB Liggett S Cresci RJ Kelly FM Syed SJ Matkovich HS Hahn A Diwan JS Martini L Sparks RR Parekh, Nature medicine 2008 14 510 517 18425130 10.1038/nm1750
24. Individual genomes instead of race for personalized medicine. PC Ng Q Zhao S Levy RL Strausberg JC Venter, Clinical pharmacology and therapeutics 2008 84 306 309 10.1038/clpt.2008.114
25. The diploid genome sequence of an individual human. S Levy G Sutton PC Ng L Feuk AL Halpern BP Walenz N Axelrod J Huang EF Kirkness G Denisov, PLoS biology 2007 5 e254 17803354 10.1371/journal.pbio.0050254
26. The complete genome of an individual by massively parallel DNA sequencing. DA Wheeler M Srinivasan M Egholm Y Shen L Chen A McGuire W He YJ Chen V Makhijani GT Roth, Nature 2008 452 872 876 10.1038/nature06884 18421352
27. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA: a cancer journal for clinicians 2008 58 71 96 10.3322/CA.2007.0010 18287387
28. Racial and ethnic disparities in the receipt of cancer treatment. VL Shavers ML Brown, Journal of the National Cancer Institute 2002 94 334 357 11880473 (Pubitemid 34257478)
29. Disaggregating the effects of race and poverty on breast cancer outcomes. OW Brawley, Journal of the National Cancer Institute 2002 94 471 473 11929941 (Pubitemid 34411280)
30. 8q24 and prostate cancer: association with advanced disease and meta-analysis. I Cheng SJ Plummer E Jorgenson X Liu BA Rybicki G Casey JS Witte, Eur J Hum Genet 2008 16 496 505 10.1038/sj.ejhg.5201959 18231127
31. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. ML Freedman CA Haiman N Patterson GJ McDonald A Tandon A Waliszewska K Penney RG Steen K Ardlie EM John, Proceedings of the National Academy of Sciences of the United States of America 2006 103 14068 14073 16945910 10.1073/pnas.0605832103
32. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. C Robbins JB Torres S Hooker C Bonilla W Hernandez A Candreva C Ahaghotu R Kittles J Carpten, Genome research 2007 17 1717 1722 17978284 10.1101/gr.6782707
33. Multiple prostate cancer risk variants on 8q24. JS Witte, Nature genetics 2007 39 579 580 10.1038/ng0507-579 17460686
34. Multiple regions within 8q24 independently affect risk for prostate cancer. CA Haiman N Patterson ML Freedman SR Myers MC Pike A Waliszewska J Neubauer A Tandon C Schirmer GJ McDonald, Nature genetics 2007 39 638 644 17401364 10.1038/ng2015
35. Strengthening the role of genomics in global health. T Acharya AS Daar H Thorsteinsdottir E Dowdeswell PA Singer, PLoS medicine 2004 1 e40 15630462 10.1371/journal.pmed.0010040
36. Generations of sequencing technologies. E Pettersson J Lundeberg A Ahmadian, Genomics 2008
37. Proportionally more deleterious genetic variation in European than in African populations. KE Lohmueller AR Indap S Schmidt AR Boyko RD Hernandez MJ Hubisz JJ Sninsky TJ White SR Sunyaev R Nielsen, Nature 2008 451 994 997 10.1038/nature06611 18288194
38. On the origin of deleterious mutations. E Check-Hayden, Nature 2008 451 876 10.1038/451876a 18288151
39. Unnatural causes.is inequality making us sick? California Newsreel, Vital Pictures, [videorecording] San Francisco, CA: California Newsreel 2008
40. World Health Organization. Advisory Committee on Health Research, Genomics and world health: report of the Advisory Committee on Health Research Geneva: World Health Organization 2002